Ponoi II Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Ponoi II Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,574,229	Closed	-$53.2M	–	5
2021 Q2	$53.2M	Hold	1,574,229	–	–	43.12%	1
2021 Q1	$36.8M	Hold	1,574,229	–	–	28.2%	2
2020 Q4	$45.3M	Buy	+1,574,229	New	+$39.6M	33.03%	1

Ponoi II Management's CNST Position: Q3 2021 in Review

Ponoi II Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 1,574,229 shares — an estimated $53.2M sold.

Ponoi II Management first reported a position in CNST in Q4 2020 and held it in 3 quarters. The position peaked at $53.2M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Ponoi II Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Ponoi II Management sold 1,574,229 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $53.2M.
Ponoi II Management first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2020 and held it in 3 quarters.
Ponoi II Management's Constellation Pharmaceuticals, Inc. position peaked at $53.2M in Q2 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Ponoi II Management's 13F filing for Q3 2021, filed 12 Nov 2021.